126 related articles for article (PubMed ID: 18830898)
1. Alterations of peripheral blood CD5+ B cells in inflammatory bowel disease.
Mishima Y; Ishihara S; Amano Y; Oshima N; Kadota C; Otani A; Moriyama I; Li YY; Aziz MM; Kinoshita Y
Scand J Gastroenterol; 2009; 44(2):172-9. PubMed ID: 18830898
[TBL] [Abstract][Full Text] [Related]
2. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
3. Depletion of immunoglobulin M memory B cells is associated with splenic hypofunction in inflammatory bowel disease.
Di Sabatino A; Rosado MM; Ciccocioppo R; Cazzola P; Morera R; Corazza GR; Carsetti R
Am J Gastroenterol; 2005 Aug; 100(8):1788-95. PubMed ID: 16086716
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin M memory B cell decrease in inflammatory bowel disease.
Di Sabatino A; Carsetti R; Rosado MM; Ciccocioppo R; Cazzola P; Morera R; Tinozzi FP; Tinozzi S; Corazza GR
Eur Rev Med Pharmacol Sci; 2004; 8(5):199-203. PubMed ID: 15638230
[TBL] [Abstract][Full Text] [Related]
5. Increased peripheral blood B-cells expressing the CD5 molecules in association to autoantibodies in patients with lupus erythematosus and evidence to selectively down-modulate them.
Böhm I
Biomed Pharmacother; 2004 Jun; 58(5):338-43. PubMed ID: 15194170
[TBL] [Abstract][Full Text] [Related]
6. Reduced endothelial progenitor cell number and function in inflammatory bowel disease: a possible link to the pathogenesis.
Garolla A; D'Incà R; Checchin D; Biagioli A; De Toni L; Nicoletti V; Scarpa M; Bolzonello E; Sturniolo GC; Foresta C
Am J Gastroenterol; 2009 Oct; 104(10):2500-7. PubMed ID: 19568231
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of a human CD5+ pre-naive B cell population.
Lee J; Kuchen S; Fischer R; Chang S; Lipsky PE
J Immunol; 2009 Apr; 182(7):4116-26. PubMed ID: 19299709
[TBL] [Abstract][Full Text] [Related]
8. Differential susceptibility of peripheral blood CD5+ and CD5- B cells to apoptosis in chronic hepatitis C patients.
Mizuochi T; Ito M; Takai K; Yamaguchi K
Biochem Biophys Res Commun; 2009 Nov; 389(3):512-5. PubMed ID: 19737536
[TBL] [Abstract][Full Text] [Related]
9. Memory and naïve B-cell subsets in patients with multiple sclerosis.
Niino M; Hirotani M; Miyazaki Y; Sasaki H
Neurosci Lett; 2009 Oct; 464(1):74-8. PubMed ID: 19666086
[TBL] [Abstract][Full Text] [Related]
10. Differential expression patterns of recombination-activating genes in individual mature B cells in juvenile idiopathic arthritis.
Faber C; Morbach H; Singh SK; Girschick HJ
Ann Rheum Dis; 2006 Oct; 65(10):1351-6. PubMed ID: 16504994
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of CD5 on B lymphocytes in cattle infected with Mycobacterium avium subsp. paratuberculosis.
Stabel JR; Khalifeh MS
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):211-9. PubMed ID: 18692906
[TBL] [Abstract][Full Text] [Related]
12. Expression of toll-like receptors on B lymphocytes.
Dasari P; Nicholson IC; Hodge G; Dandie GW; Zola H
Cell Immunol; 2005; 236(1-2):140-5. PubMed ID: 16188245
[TBL] [Abstract][Full Text] [Related]
13. Predictors of corticosteroid-dependent and corticosteroid-refractory inflammatory bowel disease: analysis of a Chinese cohort study.
Chow DK; Sung JJ; Tsoi KK; Wong VW; Wu JC; Leong RW; Chan FK
Aliment Pharmacol Ther; 2009 Apr; 29(8):843-54. PubMed ID: 19154567
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of altered coagulation and fibrinolysis as measures of disease activity in active inflammatory bowel disease: a gender-stratified, cohort analysis.
Shen J; Ran ZH; Zhang Y; Cai Q; Yin HM; Zhou XT; Xiao SD
Thromb Res; 2009 Feb; 123(4):604-11. PubMed ID: 18499234
[TBL] [Abstract][Full Text] [Related]
15. CD5+ B cells with the features of subepithelial B cells found in human tonsils.
Dono M; Burgio VL; Colombo M; Sciacchitano S; Reverberi D; Tarantino V; Cutrona G; Chiorazzi N; Ferrarini M
Eur J Immunol; 2007 Aug; 37(8):2138-47. PubMed ID: 17615580
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of alpha- and beta-defensins in plasma of patients with inflammatory bowel disease.
Yamaguchi N; Isomoto H; Mukae H; Ishimoto H; Ohnita K; Shikuwa S; Mizuta Y; Nakazato M; Kohno S
Inflamm Res; 2009 Apr; 58(4):192-7. PubMed ID: 19184352
[TBL] [Abstract][Full Text] [Related]
17. Increased Toll-like receptor 9 expression by B cells from inflammatory bowel disease patients.
Berkowitz D; Peri R; Lavy A; Kessel A
Hum Immunol; 2013 Dec; 74(12):1519-23. PubMed ID: 24007656
[TBL] [Abstract][Full Text] [Related]
18. Correlation of autoantibodies and CD5+ B cells in ocular adnexal marginal zone B cell lymphomas.
Kubota T; Moritani S; Yoshino T; Nagai H; Terasaki H
J Clin Pathol; 2010 Jan; 63(1):79-82. PubMed ID: 20026703
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the expression of CD5 antigen on the surface of human peripheral B lymphocytes.
Kawamura M; Wheeler CJ; Notkins AL; Bich-Thuy LT
Cell Immunol; 1994 Nov; 159(1):61-76. PubMed ID: 7525082
[TBL] [Abstract][Full Text] [Related]
20. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease.
Valentini L; Wirth EK; Schweizer U; Hengstermann S; Schaper L; Koernicke T; Dietz E; Norman K; Buning C; Winklhofer-Roob BM; Lochs H; Ockenga J
Nutrition; 2009 Feb; 25(2):172-81. PubMed ID: 18849144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
